Bristol Myers Squibb, Noxopharm to partner on immunotherapy pilot
The pharma giant and the clinical-stage drug developer will join on a pilot study investigating a candidate’s potential in overcoming resistance of a cancer drug.
The pharma giant and the clinical-stage drug developer will join on a pilot study investigating a candidate’s potential in overcoming resistance of a cancer drug.
The agency has given the go-ahead for use of baricitinib in conjunction with remdesivir for treating patients hospitalized with severe cases of the virus.
A leader from the global CRO shares an update on their new Accellacare clinical research network, and perspective on the importance of patient centricity.